Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.
about
The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experiencePneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children.Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, KenyaImmunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV InfectionPneumococcal Acquisition Among Infants Exposed to HIV in Rural Malawi: A Longitudinal Household Study.Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status.Management of severe non-TB bacterial infection in HIV-infected adults.Malnutrition and vaccination in developing countries.Decline in Child Hospitalization and Mortality After the Introduction of the 7-Valent Pneumococcal Conjugative Vaccine in Rwanda.Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006-2014.Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries.Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.Burden of invasive pneumococcal disease among children in rural Mozambique: 2001-2012.Nasopharyngeal carriage of Streptococcus pneumoniae among HIV-infected and -uninfected children <5 years of age before introduction of pneumococcal conjugate vaccine in Mozambique.Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic.
P2860
Q28088507-5F11A52B-B4A7-44F9-BBE4-7A868ADE2B52Q30235055-8CD0A90D-E070-4573-94CC-F8723E0CF5E6Q33776584-834B3343-11A9-447A-A50C-6D89D504EB16Q35965212-AE3EAD08-04D7-482D-996A-F1B58C52DC5EQ36402435-02A096D0-F4F0-46A9-93BC-8C5545072DC6Q37606399-518A2A46-7FED-46FE-9530-053784D6D35BQ38314390-8C83BAF4-39FF-4E65-B97A-E0AD267BCD06Q38474417-86CE7BD0-7836-416F-A1A1-F58BD65CEE40Q39414412-9C1D9D4C-9DBD-45AB-9762-DD6BC214D65CQ40059651-CFC14904-7C5C-460A-BF9D-4BD27D51B474Q40242598-793DB5DD-A01D-47C2-BE84-DE7B37AD4E6BQ41489687-9E2E95B8-83DC-423B-8BB9-83A771CA6327Q47557816-9FEA0FDB-3CE0-4D71-83A8-FEFCF2DACD62Q49980280-9930721F-CA23-47AA-9783-F1050FC80D74Q54093232-153056AA-1F58-402B-BD8A-DFF79665CA02
P2860
Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effectiveness of 7-valent pneu ...... a matched case-control study.
@ast
Effectiveness of 7-valent pneu ...... a matched case-control study.
@en
Effectiveness of 7-valent pneu ...... a matched case-control study.
@nl
type
label
Effectiveness of 7-valent pneu ...... a matched case-control study.
@ast
Effectiveness of 7-valent pneu ...... a matched case-control study.
@en
Effectiveness of 7-valent pneu ...... a matched case-control study.
@nl
prefLabel
Effectiveness of 7-valent pneu ...... a matched case-control study.
@ast
Effectiveness of 7-valent pneu ...... a matched case-control study.
@en
Effectiveness of 7-valent pneu ...... a matched case-control study.
@nl
P2093
P2860
P50
P356
P1476
Effectiveness of 7-valent pneu ...... a matched case-control study.
@en
P2093
Babatyi Malope-Kgokong
Brian Eley
Cynthia G Whitney
Elizabeth R Zell
Gary Reubenson
Laura Conklin
Mamokgethi Moshe
Melony Fortuin-de Smit
Nireshni Naidoo
Ranmini Kularatne
P2860
P304
P356
10.1093/CID/CIU431
P407
P50
P577
2014-06-09T00:00:00Z